Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Lindor

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2012
Current therapies for nonalcoholic fatty liver diseaseA A Gossard, K D Lindor
Annals of Internal Medicine|January 15, 1993
Outcome of patients hospitalized for complications after outpatient liver biopsyC H Janes, K D Lindor
Southern Medical Journal|August 1, 1984
Symposium on upper gastrointestinal motility disorders. Gastric motor disorders: an overviewK D Lindor, J R Malagelada
Digestive Diseases (Basel, Switzerland)|January 1, 1997
Primary sclerosing cholangitis: evolving concepts in diagnosis and treatmentD M Harnois, K D Lindor
Alimentary Pharmacology & Therapeutics|January 30, 2015
Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver diseaseJ H Tabibian, K D Lindor
Seminars in Gastrointestinal Disease|May 16, 2001
Primary sclerosing cholangitisC O Zein, K D Lindor
Best Practice & Research. Clinical Gastroenterology|August 9, 2001
Natural history and prognostic models in primary sclerosing cholangitisJ A Talwalkar, K D Lindor
Current Gastroenterology Reports|September 12, 2000
Management of primary biliary cirrhosis: from diagnosis to end-stage diseaseK N Lazaridis, K D Lindor
The Medical Clinics of North America|September 1, 1996
Diagnosis and therapy of cholestatic liver diseaseT M Pasha, K D Lindor
The American Journal of Gastroenterology|August 19, 2000
Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapyD G Fong, K D Lindor
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2012
Current therapies for nonalcoholic fatty liver diseaseA A Gossard, K D Lindor
Annals of Internal Medicine|January 15, 1993
Outcome of patients hospitalized for complications after outpatient liver biopsyC H Janes, K D Lindor
Southern Medical Journal|August 1, 1984
Symposium on upper gastrointestinal motility disorders. Gastric motor disorders: an overviewK D Lindor, J R Malagelada
Digestive Diseases (Basel, Switzerland)|January 1, 1997
Primary sclerosing cholangitis: evolving concepts in diagnosis and treatmentD M Harnois, K D Lindor
Alimentary Pharmacology & Therapeutics|January 30, 2015
Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver diseaseJ H Tabibian, K D Lindor
Seminars in Gastrointestinal Disease|May 16, 2001
Primary sclerosing cholangitisC O Zein, K D Lindor
Best Practice & Research. Clinical Gastroenterology|August 9, 2001
Natural history and prognostic models in primary sclerosing cholangitisJ A Talwalkar, K D Lindor
Current Gastroenterology Reports|September 12, 2000
Management of primary biliary cirrhosis: from diagnosis to end-stage diseaseK N Lazaridis, K D Lindor
The Medical Clinics of North America|September 1, 1996
Diagnosis and therapy of cholestatic liver diseaseT M Pasha, K D Lindor
The American Journal of Gastroenterology|August 19, 2000
Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapyD G Fong, K D Lindor
Pageof 15